Market intelligence
PBLSSector not reported
Parabilis Medicines, Inc. insider activity
In the last 90 days, 15 corporate insiders purchased $2,244,196,331 of stock on the open market.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $2,244,196,331
- Corporate buyers
- 15
- Latest transaction
- Jul 22, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.